GlassScriptPhysician profile
Santo Paniello
NPI 1104830249
$1,277.77
in general payments reported to CMS, 2019-2025
16 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.00 · 2020: $32.24 · 2021: $91.70 · 2022: $637 · 2023: $174 · 2024: $141 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.87 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $530.91 | 2022 | |
| Astellas Pharma US INC | $255.57 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $82.14 | 2024-2025 | Injectafer |
| Organon LLC | $64.98 | 2023-2025 | Nexplanon, Jada System |
| Abbvie INC. | $54.31 | 2021 | |
| Smith+Nephew, INC. | $50.03 | 2022 | |
| Applied Medical Resources Corporation | $39.56 | 2022 | |
| Coopersurgical, INC. | $33.99 | 2019-2020 | |
| Pfizer INC. | $31.08 | 2019-2023 | |
| Amgen INC. | $26.23 | 2021 | |
| Exeltis, USA INC. | $24.29 | 2020-2021 | |
| Meditrina | $21.43 | 2025 | |
| Dilon Technologies, INC. | $19.41 | 2024 | Hemoblast Bellows |
| Becton, Dickinson and Company | $16.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.01 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santo Paniello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.